The California Institute for Regenerative Medicine has decided how to spend the $3 billion approved by the U.S. state's voters for stem cell research.
Institute officials say they will spend $823 million on basic stem cell research, $899 million on applied or preclinical research and $656 million for new treatments through clinical trials, The New York Times reported Thursday.
Although the San Francisco institute said it's unlikely it will be able to fully develop stem cell therapy for routine clinical use during the 10-year spending plan, it does hope to have proof of principle for a stem cell treatment of at least one disease, with another two to four treatments entering early clinical trials, the Times said.
Copyright 2006 by United Press International
Related stories:
New Membrane Model May Unlock Secrets of Early-Stage Alzheimer's
Researchers at the National Institute of Standards and Technology and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer’s disease actually impairs a neuron’s structure and function. The team’s findings are reported in a new paper in the
Biophysical Journal.
Scientists identify cells for spinal-cord repair
A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
Stem Cell Chicken and Egg Debate Moves to Unlikely Arena: The Testes
Logic says it has to be the niche. As air and water preceded life, so the niche, that hospitable environment that shelters adult stem cells in many tissues and provides factors necessary to keep them young and vital, must have emerged before its stem cell dependents.
Study identifies cells for spinal-cord repair
(PhysOrg.com) -- A researcher at MIT’s Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
Scientists use genomic tools to create maps of DNA methylation
(PhysOrg.com) -- Much of the field of stem cell biology and development remains uncharted territory. Just as famous explorers and astronomers mapped out landmasses and constellations, researchers are working fervently to chart the molecular landscapes within stem cells — especially embryonic stem cells. A clearer understanding of the cells’ unique properties, particularly their ability to give rise to nearly any type of cell, could unlock fundamental questions about biology and may even spur novel ways to treat disease.
Researchers uncover benefits of aspirin for treating osteoporosis
Researchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis. Forty-four million Americans, 68 percent of whom are women, suffer from the debilitating effects of osteoporosis according to the National Institute of Health. One out of every two women and one in four men over 50 will have an osteoporosis-related fracture in their lifetime.
Gene directs stem cells to build the heart
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.
Small protein may have big role in making more bone and less fat
A small protein may have a big role in helping you make more bone and less fat, researchers say. "The pathways are parallel, and the idea is if you can somehow disrupt the fat production pathway, you will get more bone," says Dr. Xingming Shi, bone biologist at the Medical College of Georgia Institute of Molecular Medicine and Genetics.